Ngs Reagent Kit
| Applications | Ffpe Tissues, Ngs, For Cancers |
| Tested Parameter | For Cfdna |
The AVENIO ctDNA Expanded Kit V2 is a liquid biopsy research assay that utilizes next-generation sequencing (NGS). It includes a 77-gene panel that includes genes in the U.S. National Comprehensive Cancer Network (NCCN) Guidelines1 and emerging cancer biomarkers. It is a pan-cancer assay that has been specifically optimized for the study of colorectal cancer (CRC) and lung cancer.input:
output:Advantages and Features
Contains genes that are included in the U.S. National Comprehensive Cancer Network (NCCN) Guidelines1 and emerging cancer biomarkers.A single assay that encompasses all four mutation classes (SNVs, indels, fusions, and CNVs)Exceptional analytical performance is facilitated by integrated digital error suppression (iDES) strategies that integrate molecular barcodes with in silico error suppression techniques2,3.
Included are bioinformatics, software, and reagents.
A five-day research workflow that is streamlined from extraction to analysis and reporting.
MAECENAS IACULIS
Vestibulum curae torquent diam diam commodo parturient penatibus nunc dui adipiscing convallis bulum parturient suspendisse parturient a.Parturient in parturient scelerisque nibh lectus quam a natoque adipiscing a vestibulum hendrerit et pharetra fames nunc natoque dui.
ADIPISCING CONVALLIS BULUM
- Vestibulum penatibus nunc dui adipiscing convallis bulum parturient suspendisse.
- Abitur parturient praesent lectus quam a natoque adipiscing a vestibulum hendre.
- Diam parturient dictumst parturient scelerisque nibh lectus.
Scelerisque adipiscing bibendum sem vestibulum et in a a a purus lectus faucibus lobortis tincidunt purus lectus nisl class eros.Condimentum a et ullamcorper dictumst mus et tristique elementum nam inceptos hac parturient scelerisque vestibulum amet elit ut volutpat.
